Obermeyer Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Obermeyer Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Sell	2,000 -103	-5%	-$66K	0.05%	105
2025 Q4	$1.42M	Sell	2,103 -152	-7%	-$104K	0.07%	91
2025 Q3	$1.44M	Sell	2,255 -22	-1%	-$13.4K	0.07%	89
2025 Q2	$1.22M	Sell	2,277 -109	-5%	-$52.1K	0.06%	92
2025 Q1	$1M	Sell	2,386 -207	-8%	-$89.9K	0.05%	99
2024 Q4	$1.07M	Sell	2,593 -742	-22%	-$325K	0.06%	97
2024 Q3	$1.68M	Sell	3,335 -86	-3%	-$41.8K	0.09%	79
2024 Q2	$1.67M	Sell	3,421 -319	-9%	-$160K	0.1%	79
2024 Q1	$2.02M	Sell	3,740 -633	-14%	-$346K	0.12%	68
2023 Q4	$2.43M	Hold	4,373	–	–	0.17%	43
2023 Q3	$1.91M	Sell	4,373 -105	-2%	-$52.4K	0.14%	46
2023 Q2	$2.25M	Sell	4,478 -184	-4%	-$88.2K	0.16%	44
2023 Q1	$2.33M	Sell	4,662 -834	-15%	-$399K	0.17%	46
2022 Q4	$2.24M	Sell	5,496 -65	-1%	-$25.2K	0.17%	48
2022 Q3	$1.81M	Sell	5,561 -25	-0.4%	-$9.18K	0.15%	49
2022 Q2	$1.96M	Hold	5,586	–	–	0.14%	47
2022 Q1	$3.06M	Sell	5,586 -157	-3%	-$82.6K	0.18%	43
2021 Q4	$3.78M	Sell	5,743 -128	-2%	-$80.4K	0.2%	39
2021 Q3	$3.65M	Buy	5,871 +140	+2%	+$94.1K	0.2%	42
2021 Q2	$3.62M	Sell	5,731 -355	-6%	-$196K	0.2%	46
2021 Q1	$2.98M	Sell	6,086 -65	-1%	-$32.6K	0.18%	48
2020 Q4	$3.08M	Sell	6,151 -127	-2%	-$56.8K	0.2%	41
2020 Q3	$2.47M	Sell	6,278 -139	-2%	-$51.4K	0.18%	42
2020 Q2	$2.12M	Buy	6,417 +392	+7%	+$113K	0.18%	41
2020 Q1	$1.46M	Sell	6,025 -1,012	-14%	-$264K	0.16%	43
2019 Q4	$1.84M	Sell	7,037 -55	-0.8%	-$14.5K	0.16%	48
2019 Q3	$1.93M	Sell	7,092 -150	-2%	-$41.7K	0.18%	45
2019 Q2	$1.99M	Sell	7,242 -300	-4%	-$73.9K	0.18%	46
2019 Q1	$1.69M	Sell	7,542 -430	-5%	-$88.8K	0.16%	45
2018 Q4	$1.48M	Hold	7,972	–	–	0.15%	44
2018 Q3	$1.99M	Sell	7,972 -20	-0.3%	-$4.86K	0.17%	41
2018 Q2	$1.74M	Sell	7,992 -45	-0.6%	-$9.27K	0.16%	43
2018 Q1	$1.54M	Sell	8,037 -3,060	-28%	-$565K	0.14%	42
2017 Q4	$1.74M	Sell	11,097 -300	-3%	-$47.2K	0.15%	45
2017 Q3	$1.77M	Sell	11,397 -4,224	-27%	-$668K	0.15%	44
2017 Q2	$2.52M	Sell	15,621 -428	-3%	-$69.5K	0.22%	41
2017 Q1	$2.48M	Sell	16,049 -200	-1%	-$27.6K	0.23%	40
2016 Q4	$1.91M	Sell	16,249 -1,170	-7%	-$134K	0.18%	41
2016 Q3	$1.96M	Buy	17,419 +220	+1%	+$23.2K	0.19%	42
2016 Q2	$1.6M	Sell	17,199 -5,400	-24%	-$464K	0.16%	43
2016 Q1	$1.77M	Buy	22,599 +250	+1%	+$18K	0.16%	42
2015 Q4	$1.63M	Sell	22,349 -2,401	-10%	-$171K	0.15%	41
2015 Q3	$1.84M	Sell	24,750 -230	-0.9%	-$16.5K	0.19%	40
2015 Q2	$1.6M	Sell	24,980 -4,460	-15%	-$309K	0.14%	48
2015 Q1	$2.27M	Sell	29,440 -1,380	-4%	-$107K	0.19%	58
2014 Q4	$2.29M	Buy	+30,820	New	+$2.16M	0.21%	59

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Obermeyer Wealth Partners's IDXX Position: Q1 2026 in Review

Obermeyer Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 4.9% in Q1 2026, selling an estimated $66K and leaving 2,000 shares worth $1.12M. The position accounts for 0.05% of the portfolio, ranked #105.

Obermeyer Wealth Partners first reported a position in IDXX in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.78M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Obermeyer Wealth Partners held 2,000 shares of Idexx Laboratories worth $1.12M as of Q1 2026.
Obermeyer Wealth Partners sold 103 Idexx Laboratories shares in Q1 2026, an estimated $66K.
Idexx Laboratories made up 0.05% of Obermeyer Wealth Partners's portfolio in Q1 2026, its #105 holding.
Obermeyer Wealth Partners first reported a position in Idexx Laboratories in Q4 2014 and has held it in 46 quarters since.
Obermeyer Wealth Partners's Idexx Laboratories position peaked at $3.78M in Q4 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q1 2026, filed 21 Apr 2026.